Allosteric modulation of adenosine A1 receptor coupling to G-proteins in brain

Journal of Neurochemistry

Volumn 93, Issue 3, 2005, Pages 715-723

  Childers, Steven R ^a   Li, Xinhui ^a   Xiao, Ruoyu ^a   Eisenach, James C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

35S GTP S; Adenosine A1 receptor; Allosteric; Autoradiography; G proteins; Modulator

Indexed keywords

2 AMINO 4,5,6 TETRAHYDROBENZO(BETA)THIOPHEN 3 YL 4 CHLOROPHENYLMETHANONE; ADENOSINE A1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PHENYLISOPROPYLADENOSINE; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG EFFICACY; MALE; NEUROANATOMY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

ALLOSTERIC REGULATION; ANIMALS; BRAIN; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1;

EID: 18144408044     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03044.x     Document Type: Article

References (34)

1. Baker S. P., Scammells P. J. and Belardinelli L. (2000) Differential A (1)-adenosine receptor reserve for inhibition of cyclic AMP accumulation and G-protein activation in DDT (1) MF-2 cells. Br. J. Pharmacol. 130, 1156-1164.
2. 1 adenosine receptor. J. Med. Chem. 46, 794-809.
3. 1 adenosine receptor coupling to G proteins. Biochim. Biophys. Acta 1265, 15-21.
4. Bradford M. M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. 1 receptor binding and function by 2-amino-3-benzoylthiophenes. Mol. Pharmacol. 38, 939-949.
6. 1 receptor binding by 2-amino-3- benzoylthiophenes. Mol. Pharmacol. 38, 950-958.
7. Chiari A. I. and Eisenach J. C. (1999) Intrathecal adenosine: Interactions with spinal clonidine and neostigmine in rat models of acute nociception and postoperative surgery. Anesthesiology 90, 1413-1421.
8. De Vry J., Kuhl E., Franken-Kunkel P. and Eckel G. (2004) Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur. J. Pharmacol. 491, 137-148.
9. 1 adenosine receptor ligands. Curr. Top. Med. Chem. 3, 369-385.
10. Eisenach J. C., Rauck R. L. and Curry R. (2003) Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain. Pain 105, 65-70.
11. 1 receptors in rat brain, as revealed by autoradiography. Neuroscience 34, 759-769.
12. 1 adenosine receptors increase receptor-G-protein coupling and counteract guanine nucleotide effects on agonist binding. Mol. Pharmacol. 64, 1557-1564.
13. Gao Z.-G., Gross A. S. and Jacobson K. A. (2004) Effects of the allosteric modulator SCH-202676 on adenosine and P2Y receptors. Life Sci. 74, 3173-3180.
14. Gierschik P., Moghtader R., Straub C., Dieterich K. and Jakobs K. H. (1991) Signal amplification in HL-60 granulocytes: Evidence that the chemotactic peptide receptor catalytically activates guanine-nucleotide-binding regulatory proteins in native plasma membranes. Eur. J. Biochem. 197, 725-732.
15. Gomes J. A., Li X. H., Pan H. L. and Eisenach J. C. (1999) Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats. Anesthesiology 91, 1072-1079.
16. 1 receptor. Biochem. Pharmacol. 61, 137-144.
17. Lavand'homme P. M. and Eisenach J. C. (1999) Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain. Pain 80, 31-36.
18. Li X., Conklin D., Pan H. L. and Eisenach J. C. (2003) Allosteric adenosine receptor modulation reduces hypersensitivity following peripheral inflammation by a central mechanism. J. Pharmacol. Exp. Ther. 305, 950-955.
19. 1 receptor produces tolerance in rats with neuropathic pain. Anesthesiology 100, 956-961.
20. 35S]thio) triphosphate binding. Mol. Pharmacol. 44, 115-123.
21. Lorenzen A., Guerra L., Vogt H. and Schwabe U. (1996) Interaction of full and partial agonists of the A1 adenosine receptor with receptor/ G protein complexes in rat brain membranes. Mol. Pharmacol. 49, 915-926.
22. 1 adenosine agonist binding: new 3,4- and 5-modifications. J. Med. Chem. 46, 1870-1877.
23. 35S]GTPγS binding in brain: modulation by endogenous adenosine. Neuropharmacology 39, 282-289.
24. 1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723. J. Pharmacol. Exp. Ther. 288, 446-454.
25. van dem Nieuwendijk A. M. C. H., Pietra D., Heitman L., Goblyos A. and Ijzerman A. P. (2004) Synthesis and biological evaluation of 2,3,5-substituted [1,2,4]thiodiazoles as allosteric modulators of adenosine receptors. J. Med. Chem. 47, 663-672.
26. Obata H., Li X. and Eisenach J. C. (2004) Spinal adenosine receptor activation reduces hypersensitivity after surgery by a different mechanism than after nerve injury. Anesthesiology 100, 1258-1262.
27. Pan H. L., Zemin X., Leung E. and Eisenach J. C. (2001) Allosteric adenosine modulation to reduce allodynia. Anesthesiology 95, 416-420.
28. 35S]GTPγS binding in rat thalamus and cultured cell lines: Signal transduction mechanisms underlying agonist efficacy. Mol. Pharmacol. 51, 87-96.
29. 35S]GTPγS binding in mMOR-CHO cells and rat thalamus. J. Pharmacol. Exp. Ther. 285, 496-505.
30. 35S]thio]-triphosphate binding. Proc. Natl Acad. Sci. USA 92, 7242-7246.
31. 35S]GTPγS autoradiography in rat brain. J. Neurosci. 16, 8057-8066.
32. Sim L. J., Selley D. E., Xiao R. and Childers S. R. (1996b) Differences in G-protein activation by mu and delta-opioid, cannabinoid receptors in rat striatum. Eur. J. Pharmacol. 307, 97-105.
33. 35S]GTPγS binding in rat brain: Evidence for partial agonistactivity at mu opioid receptors. J. Neurochem. 70, 1567-1576.
34. 35S]thio) triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 47, 848-854.